Alcoholism Clinical Trial
— CoVADOfficial title:
Study of Mental Flexibility and Inhibition Processes as Cognitive Vulnerability Markers of Alcohol Dependence
The purpose of this study is to specify the cognitive and genetic pattern associated with alcohol dependence. Results will help identifying more precisely vulnerability factors associated with this disorder.
Status | Terminated |
Enrollment | 261 |
Est. completion date | July 2009 |
Est. primary completion date | March 2009 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: Alcohol-dependent patients : - Males or females, aged 18-65 years, with a diagnosis of alcohol dependence, according to the DSM-IV criteria - Patients withdrawn from alcohol at least 2 weeks - Native French speaker, able to read French and complete study evaluations - Caucasian - Able to provide informed written and verbal consent First-degree relatives of alcohol-dependent probands : - Males or females, aged 18-65 years - Caucasian - Native French speaker, able to read French and complete study evaluations - Able to provide informed written and verbal consent Healthy Controls : - Males or females, aged 18-65 years - Caucasian - Native French speaker, able to read French and complete study evaluations - Able to provide informed written and verbal consent Exclusion Criteria: Alcohol-dependent patients - DSM-IV substance use disorder other than alcohol - Severe chronic psychiatric disorders including Bipolar disorder and schizophrenia - Mood episode diagnostic according to the DSM-IV criteria in the last six months - A significant general medical illness, including neurological disorders - A sensorial impairment uncorrected (visual and/or hearing) - Individuals who are not covered by national health insurance First-degree relatives of alcohol-dependent probands : - Past or recent alcohol and/or drug abuse or dependence - Severe chronic psychiatric disorders including Bipolar disorder and schizophrenia - Mood episode diagnostic according to the DSM-IV criteria in the last six months - A significant general medical illness, including neurological disorders - Handling of psychotropics substances - A sensorial impairment uncorrected (visual and/or hearing) - Individuals who are not covered by national health insurance Healthy Controls : - A personal or first-degree-relative history of alcohol dependence - Past or recent alcohol and/or drug abuse or dependence - Total abstinence from alcohol - Severe chronic psychiatric disorders including Bipolar disorder and schizophrenia - Mood episode diagnostic according to the DSM-IV criteria in the last six months - A significant general medical illness, including neurological disorders - Handling of psychotropics substances - A sensorial impairment uncorrected (visual and/or hearing) - Individuals who are not covered by national health insurance |
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label
Country | Name | City | State |
---|---|---|---|
France | Chu de Reims | Reims |
Lead Sponsor | Collaborator |
---|---|
CHU de Reims |
France,
Benzerouk F, Gierski F, Gorwood P, Ramoz N, Stefaniak N, Hübsch B, Kaladjian A, Limosin F. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and its implication in executive functions in adult offspring of alcohol-dependent probands. Alcohol. 2013 Jun;47(4):271-4. doi: 10.1016/j.alcohol.2013.03.001. Epub 2013 Apr 10. — View Citation
Benzerouk F, Gierski F, Raucher-Chéné D, Ramoz N, Gorwood P, Kaladjian A, Limosin F. Association study between reward dependence and a functional BDNF polymorphism in adult women offspring of alcohol-dependent probands. Psychiatr Genet. 2015 Oct;25(5):208-11. doi: 10.1097/YPG.0000000000000099. — View Citation
Gierski F, Hubsch B, Stefaniak N, Benzerouk F, Cuervo-Lombard C, Bera-Potelle C, Cohen R, Kahn JP, Limosin F. Executive functions in adult offspring of alcohol-dependent probands: toward a cognitive endophenotype? Alcohol Clin Exp Res. 2013 Jan;37 Suppl 1:E356-63. doi: 10.1111/j.1530-0277.2012.01903.x. Epub 2012 Dec 14. — View Citation
Raucher-Chéné D, Gierski F, Hübsch B, Cuervo-Lombard CV, Bera-Potelle C, Cohen R, Kahn JP, Kaladjian A, Limosin F. Depression, anxiety and personality dimensions in female first-degree relatives of alcohol-dependent probands. Arch Womens Ment Health. 2012 Jun;15(3):229-32. doi: 10.1007/s00737-012-0271-5. Epub 2012 Mar 13. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | questionnaire | comparison of questionnaires score for the 3 groups | Day 0 | No |
Secondary | genetic polymorphism | Day 0 | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05054738 -
CRP and S&A for Inpatient Veterans
|
N/A | |
Completed |
NCT02233738 -
Group Motivational Interviewing (GMI) For Homeless Veterans In VA Services
|
N/A | |
Completed |
NCT05877807 -
Effect of Baclofen to Prevent Post-Traumatic Stress Disorder
|
||
Completed |
NCT00000437 -
Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)
|
Phase 4 | |
Completed |
NCT00536146 -
The Stress-Hormone System in Alcohol-Dependent Subjects
|
N/A | |
Terminated |
NCT00890149 -
Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults
|
Phase 2 | |
Completed |
NCT02939352 -
The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues
|
Early Phase 1 | |
Completed |
NCT02179749 -
Mifepristone Treatment of Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT01553136 -
Varenicline Treatment of Alcohol Dependence in Smokers
|
Phase 2 | |
Terminated |
NCT01408641 -
Topiramate for Alcohol Use in Posttraumatic Stress Disorder
|
N/A | |
Completed |
NCT01389297 -
Overcoming Addictions: A Randomized Clinical Trial of a Web Application Based on SMART Recovery
|
N/A | |
Completed |
NCT01113164 -
Matching Genotypes and Serotonergic Medications for Alcoholism
|
Phase 1 | |
Completed |
NCT01760785 -
Valproate for Mood Swings and Alcohol Use Following Head Injury
|
N/A | |
Completed |
NCT00768508 -
Combined Pharmacotherapies for Alcoholism
|
Phase 3 | |
Completed |
NCT00127231 -
Brief Therapy Intervention for Heavy/Hazardous Drinking in HIV-Positive Women
|
N/A | |
Completed |
NCT00367575 -
An Internet-based Intervention for Problem Drinking
|
N/A | |
Completed |
NCT00223639 -
New Medications to Treat Alcohol Dependence
|
Phase 2 | |
Completed |
NCT00583440 -
12-step Facilitation for the Dually Diagnosed
|
Phase 1/Phase 2 | |
Completed |
NCT00167687 -
Prazosin Alcohol Dependence IVR Study
|
Phase 4 | |
Recruiting |
NCT00447785 -
Endocrine Regulation of Energy and Fluid Supplies in Alcoholic Patients
|
N/A |